Brief: Indaptus Therapeutics Inc - Company Had Cash, Cash Equivalents And Short-Term Investments Of Approximately $33.0 Mln
08/08/2022 13:11
Aug 8 (Reuters) - Indaptus Therapeutics Inc INDP.O :
* INDAPTUS THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES
CORPORATE UPDATE
* Q2 LOSS PER SHARE $0.46
* AS OF JUNE 30, 2022, COMPANY HAD CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS OF APPROXIMATELY $33.0 MILLION
Source text for Eikon: ID:nGNX7d0rhB
Further company coverage: INDP.O
((Reuters.Briefs@thomsonreuters.com;))